Seya T, Tejima H, Fukuda H, Hara T, Matsumoto M, Hatanaka M, Sugita Y, Masaoka T
Department of Immunology, Center for Adult Diseases Osaka, Japan.
Leuk Res. 1993 Oct;17(10):895-6. doi: 10.1016/0145-2126(93)90155-e.
CD59 is a phosphatidyl inositol-anchored protein (which is lost in paroxysmal nocturnal hemoglobinuria (PNH) cells) with the capacity to block the formation of membrane attack complex, and protects host cells from autologous complement-mediated cytolysis. We found a patient with acute promyelocytic leukemia (APL) accompanied by disseminated intravascular coagulation (DIC), the cells of which were CD59-negative. Although the CD59 deficiency in the malignant cells was not related to PNH, we offered the possibility that DIC was induced by APL lysis secondary to the deficiency of CD59.
CD59是一种磷脂酰肌醇锚定蛋白(在阵发性夜间血红蛋白尿(PNH)细胞中缺失),具有阻止膜攻击复合物形成的能力,并保护宿主细胞免受自体补体介导的细胞溶解。我们发现一名急性早幼粒细胞白血病(APL)伴弥散性血管内凝血(DIC)的患者,其细胞CD59呈阴性。尽管恶性细胞中的CD59缺乏与PNH无关,但我们提出了DIC是由CD59缺乏继发的APL溶解所诱导的可能性。